25 September 2014 Strategies for leukemic biomarker detection using long-range surface plasmon-polaritons
Author Affiliations +
Proceedings Volume 9288, Photonics North 2014; 92880W (2014) https://doi.org/10.1117/12.2075204
Event: Photonics North 2014, 2014, Montréal, Canada
Abstract
The suitability and use of long-range surface plasmon-polaritons for leukemic biomarker detection is discussed. A novel optical biosensor comprised of gold straight waveguides embedded in CYTOP with an etched microfluidic channel was tested for detecting leukemia in patient serum. Gold surface functionalization involved the interaction of protein G (PG) with antibodies by first adsorbing PG on bare gold and then antibodies (Immunoglobulin G, IgG). Differentiation between healthy and leukemia patients was based on the difference in ratios of Ig kappa (Igκ) and Ig lambda (Igλ) light chains in both serums. The ratio for a normal patient is ~1.4 - 2, whereas for a leukemia patient this ratio is altered. As a receptor (primary antibodies), goat anti-human anti-IgGκ and anti-IgGλ were used to functionalize the surface. Diluted normal and leukemia patient serums were tested over the aforementioned surfaces. The ratios of mass surface densities of IgGκ:IgGλ for normal serum (NS) and patient serum (PS) were found to be 1.55 and 1.92 respectively.
© (2014) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
O. Krupin, O. Krupin, C. Wang, C. Wang, P. Berini, P. Berini, } "Strategies for leukemic biomarker detection using long-range surface plasmon-polaritons", Proc. SPIE 9288, Photonics North 2014, 92880W (25 September 2014); doi: 10.1117/12.2075204; https://doi.org/10.1117/12.2075204
PROCEEDINGS
11 PAGES


SHARE
Back to Top